As­traZeneca launch­es men­tal health hub for blood can­cer pa­tients and care­givers

A can­cer di­ag­no­sis of­ten rings alarm bells, and a not-sur­pris­ing re­ac­tion is want­i­ng to act quick­ly. How­ev­er, when it comes to chron­ic blood can­cers, a com­mon rec­om­men­da­tion for ac­tive sur­veil­lance, or “watch and wait,” as it’s of­ten called, can present men­tal health chal­lenges.

With slow-grow­ing chron­ic lym­pho­cyt­ic leukemia (CLL), the most com­mon form of adult leukemia, even treat­ment of­ten comes with the caveat of “liv­ing with” and man­ag­ing the dis­ease ver­sus oth­er types of can­cer where suc­cess­ful treat­ment means no signs of can­cer.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER